MIGDAL HA'EMEQ, Israel, Sept. 28, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) today announced that the underwriters of its initial public offering had exercised in full their option to purchase an additional 661,800 ordinary shares from the Company at the initial public offering price. The offering is expected to close on October 2, 2013, subject to customary closing conditions.
Enzymotec Ltd. Announces Exercise In Full Of Option To Purchase Additional Shares Related To Previously Priced Initial Public Offering
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.